SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $44.70 | 52-week high | $48.76 |
Prev. close | $43.73 | 52-week low | $38.88 |
Day low | $44.04 | Volume | 54,217 |
Day high | $44.70 | Avg. volume | 30,067 |
50-day MA | $44.86 | Dividend yield | 1.55% |
200-day MA | $42.98 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 164.20M |
Net Asset Value (NAV) | $43.78 |
Options? | Yes |
Total Holdings | 48 |
XPH Top Holdings
Symbol | Company | % of Total |
ITCI | INTRA CELLULAR THERAPIES INC | 5.4% |
RPRX | ROYALTY PHARMA PLC CL A | 4.41% |
PFE | PFIZER INC | 3.77% |
OGN | ORGANON + CO | 3.7% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 3.64% |
MRK | MERCK + CO. INC. | 3.62% |
JNJ | JOHNSON + JOHNSON | 3.62% |
BMY | BRISTOL MYERS SQUIBB CO | 3.57% |
AXSM | AXSOME THERAPEUTICS INC | 3.44% |
ELAN | ELANCO ANIMAL HEALTH INC | 3.44% |
XPH Price Returns
1-mo | 3.32% |
3-mo | -2.96% |
6-mo | 5.39% |
1-year | 7.77% |
3-year | 10.95% |
5-year | 0.51% |
YTD | 3.98% |
2024 | 4.94% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |